All In MedTech

Device Trial Radar · NCT04430075

MiCLASP Post Market Clinical Follow-Up (PMCF) Study

Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)

Last checked: Nov 20, 2026Latest source record: Aug 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

1,000

Planned (sponsor's estimate)

Start

Aug 23, 2019

Primary completion

Sep 4, 2025

Study completion Mar 31, 2031

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Jun 12, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter mitral valve repair.

Conditions

  • Mitral Regurgitation
  • Mitral Insufficiency

Interventions

  • Edwards PASCAL Transcatheter Valve Repair System and Edwards PASCAL Precision Transcatheter Valve Repair SystemDevice

    Transcatheter Valve Repair with Edwards PASCAL and PASCAL Precision System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with major adverse events (MAE rates)Time frame: 30 days
  2. Change in mitral regurgitation severity (scale of 0-4+) by echocardiographyTime frame: Discharge: defined as discharge or 7 days post-procedure, whichever comes first

Locations

37 sites in 9 countries. Site status is shown where the registry gives one.

  • Medizinische Universität Wien/AKH Wien

    Vienna, Austria

  • Zentralklinik Bad Berka GmbH

    Bad Berka, Germany

  • Charité Berlin

    Berlin, Germany

34 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.